Skip to main content
Article
Initial experience with Imacor hTEE-guided management of patients following transplant and mechanical circulatory support.
Department of Cancer Biology Faculty Papers
  • Christopher Kang
  • Hitoshi Hirose, Thomas Jefferson University
  • Harold Hasting
Document Type
Article
Publication Date
11-1-2012
Disciplines
Comments

This article has been peer reviewed. It is the authors' final version prior to publication in ICU Director

August 22, 2012.

The published version is available at DOI:10.1177/1944451612456703. Copyright © Sage

Abstract

We reviewed an initial experience using a miniaturized transesophageal echocardiography (TEE) probe (ImaCor, Garden City, NY) with 3 patients in whom Imacor hTEE intervention was used as a point of care device to manage extracorporeal membrane oxygenation cannula placement, cardiac hemodynamics, and post-op cardiac pathophysiology. The management of transplant or mechanical circulatory support (MCS) patients is especially challenging: transplanted hearts pose unique pathophysiological challenges, and MCS significantly alters pressure-volume-flow relationships. Real-time “hemodynamic” TEE (hTEE) can help provide effective management by direct visualization of cardiac filling and function and help guide hemodynamic management. In our initial experience, hTEE can provide point-of-care management following transplant or MCS.

Citation Information
Christopher Kang, Hitoshi Hirose, Harold Hasting and. "Initial experience with Imacor hTEE-guided management of patients following transplant and mechanical circulatory support." (2012)
Available at: http://works.bepress.com/clickbank/79/